Prospective Study of Pravastatin in Elderly People at Risk (PROSPER)

From Aaushi
Jump to navigation Jump to search

Introduction

Epidemiologic study ongoing in 2001 in Scotland, Ireland & the Netherlands.

Patient population:

Study monitors:

Pravastatin 40 mg/day vs placebo

Results:

More general terms

Additional terms

References

  1. Marx J. Science 294:508, 2001
  2. Journal Watch 23(3):23, 2003 Shepherd J et al, Pravstatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 36:1623, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12457784 Collins R & Armitage J, High risk elderly patients PROSPER from cholesterol-lowering therapy. Lancet 360:1618, 2002 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12457780 <Internet> http://www.thelancet.com/journal/vol360/iss9346/full/llan.360.9346.original_research.23196.1